标题
Emerging drugs for the treatment of anxiety
作者
关键词
-
出版物
EXPERT OPINION ON EMERGING DRUGS
Volume 20, Issue 3, Pages 393-406
出版商
Informa Healthcare
发表日期
2015-05-27
DOI
10.1517/14728214.2015.1049996
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Aripiprazole as Augmentation Treatment of Refractory Generalized Anxiety Disorder and Panic Disorder
- (2016) Elizabeth A. Hoge et al. CNS SPECTRUMS
- Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders
- (2015) N. Singewald et al. PHARMACOLOGY & THERAPEUTICS
- FAAH genetic variation enhances fronto-amygdala function in mouse and human
- (2015) Iva Dincheva et al. Nature Communications
- Amygdala-Hippocampal Volume and the Phenotypic Heterogeneity of Posttraumatic Stress Disorder
- (2015) Robert H. Pietrzak et al. JAMA Psychiatry
- The Dopamineβ-Hydroxylase Inhibitor, Nepicastat, Reduces Different Alcohol-Related Behaviors in Rats
- (2014) Giancarlo Colombo et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Conditional Inactivation of Neuropeptide Y Y1 Receptors Unravels the Role of Y1 and Y5 Receptors Coexpressing Neurons in Anxiety
- (2014) Angela Longo et al. BIOLOGICAL PSYCHIATRY
- The endocannabinoid system modulates stress, emotionality, and inflammation
- (2014) Molly S. Crowe et al. BRAIN BEHAVIOR AND IMMUNITY
- Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders
- (2014) Olena Bukalo et al. BRITISH JOURNAL OF PHARMACOLOGY
- Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder
- (2014) Pablo Roitman et al. CLINICAL DRUG INVESTIGATION
- Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents
- (2014) Daniel F Connor et al. EXPERT OPINION ON PHARMACOTHERAPY
- A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder
- (2014) Atul R. Mahableshwarkar et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Efficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
- (2014) Michael E. Thase et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Agomelatine in Generalized Anxiety Disorder
- (2014) Dan J. Stein et al. JOURNAL OF CLINICAL PSYCHIATRY
- Ketamine Safety and Tolerability in Clinical Trials for Treatment-Resistant Depression
- (2014) Le-Ben Wan et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effect of Pregabalin Augmentation in Treatment of Patients with Combat-Related Chronic Posttraumatic Stress Disorder
- (2014) MEHDI BANIASADI et al. Journal of Psychiatric Practice
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
- (2014) A. McGirr et al. PSYCHOLOGICAL MEDICINE
- Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: study protocol for a randomized controlled trial
- (2014) Boadie W Dunlop et al. Trials
- The RDoC framework: facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathology
- (2014) Bruce N. Cuthbert World Psychiatry
- Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder
- (2014) Adriana Feder et al. JAMA Psychiatry
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Neuropeptide Y Receptor Gene Expression in the Primate Amygdala Predicts Anxious Temperament and Brain Metabolism
- (2013) Patrick H. Roseboom et al. BIOLOGICAL PSYCHIATRY
- FROM THE NEUROBIOLOGY OF EXTINCTION TO IMPROVED CLINICAL TREATMENTS
- (2013) Filomene G. Morrison et al. DEPRESSION AND ANXIETY
- Vortioxetine: First Global Approval
- (2013) Andrew Gibb et al. DRUGS
- Treatment of anxiety disorders in epilepsy: An evidence-based approach
- (2013) Marco Mula EPILEPSIA
- The discovery and development of vilazodone for the treatment of depression: a novel antidepressant or simply another SSRI?
- (2013) Lee A Dawson Expert Opinion on Drug Discovery
- Glutamate-based anxiolytic ligands in clinical trials
- (2013) Joanna M Wierońska et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
- (2013) Dan J Stein et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- An Open-Label Study of Guanfacine Extended Release for Traumatic Stress Related Symptoms in Children and Adolescents
- (2013) Daniel F. Connor et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
- (2013) A Neumeister et al. MOLECULAR PSYCHIATRY
- 50 years of hurdles and hope in anxiolytic drug discovery
- (2013) Guy Griebel et al. NATURE REVIEWS DRUG DISCOVERY
- D-Cycloserine Augmentation of Exposure Therapy for Post-Traumatic Stress Disorder: A Pilot Randomized Clinical Trial
- (2013) JoAnn Difede et al. NEUROPSYCHOPHARMACOLOGY
- Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept
- (2013) Carolyn I Rodriguez et al. NEUROPSYCHOPHARMACOLOGY
- Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats
- (2013) L.I. Serova et al. NEUROSCIENCE
- Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder
- (2013) Renu Sah et al. PSYCHONEUROENDOCRINOLOGY
- The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons
- (2013) Pim Cuijpers et al. World Psychiatry
- Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder
- (2012) Michael H. Bloch et al. BIOLOGICAL PSYCHIATRY
- EFFECTS OF ARIPIPRAZOLE AUGMENTATION IN TREATMENT-RESISTANT OBSESSIVE-COMPULSIVE DISORDER (A DOUBLE BLIND CLINICAL TRIAL)
- (2012) Mehdi Sayyah et al. DEPRESSION AND ANXIETY
- Vortioxetine (Lu AA21004) 5mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States
- (2012) Anthony J. Rothschild et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial
- (2012) Leszek Bidzan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Synergistic mechanisms involved in the antidepressant effects of agomelatine
- (2012) Daniela Tardito et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Lu AA21004, a multimodal psychotropic agent, in the prevention of relapse in adult patients with generalized anxiety disorder
- (2012) David S. Baldwin et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Agomelatine Prevents Relapse in Generalized Anxiety Disorder
- (2012) Dan J. Stein et al. JOURNAL OF CLINICAL PSYCHIATRY
- Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
- (2012) Guy Griebel et al. NATURE REVIEWS DRUG DISCOVERY
- Biological studies of post-traumatic stress disorder
- (2012) Roger K. Pitman et al. NATURE REVIEWS NEUROSCIENCE
- Endocannabinoid system and mood disorders: Priming a target for new therapies
- (2012) Vincenzo Micale et al. PHARMACOLOGY & THERAPEUTICS
- Central functions of neuropeptide Y in mood and anxiety disorders
- (2011) Gang Wu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Pregabalin augmentation in treatment-resistant obsessive–compulsive disorder
- (2011) Panagiotis Oulis et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder
- (2011) Charles Merideth et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Evidence-based pharmacological treatment of generalized anxiety disorder
- (2011) David S. Baldwin et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Adjunctive Risperidone Treatment for Antidepressant-Resistant Symptoms of Chronic Military Service–Related PTSD
- (2011) John H. Krystal JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Double-Blind Study of Once-Daily Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder
- (2011) Arifulla Khan et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Effect of Aripiprazole Augmentation of Serotonin Reuptake Inhibitors or Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder
- (2011) Maria Rosaria A. Muscatello et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
- (2011) Benny Bang-Andersen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
- (2011) Mateus M Bergamaschi et al. NEUROPSYCHOPHARMACOLOGY
- Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder
- (2011) Amy L. Mahan et al. TRENDS IN NEUROSCIENCES
- Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects
- (2011) Eva Marco Frontiers in Behavioral Neuroscience
- Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic properties
- (2010) John E. Tellew et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists
- (2010) John H. Krystal et al. CNS DRUGS
- Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder
- (2010) Vladimir Coric et al. DEPRESSION AND ANXIETY
- The relationship between anxiety disorders and suicide attempts: findings from the National Epidemiologic Survey on Alcohol and Related Conditions
- (2010) Josh Nepon et al. DEPRESSION AND ANXIETY
- Therapeutic potential of neuropeptide Y (NPY) receptor ligands
- (2010) Shaun P. Brothers et al. EMBO Molecular Medicine
- A selective neurokinin-1 receptor antagonist in chronic PTSD: A randomized, double-blind, placebo-controlled, proof-of-concept trial
- (2010) Sanjay J. Mathew et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- The Burden of Anxiety Disorders on the Family
- (2010) Rhandi Senaratne et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- Aripiprazole in the treatment of posttraumatic stress disorder: an open-label trial
- (2010) Marcelo Feijo Mello et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Low Cerebrospinal Fluid Neuropeptide Y Concentrations in Posttraumatic Stress Disorder
- (2009) Renu Sah et al. BIOLOGICAL PSYCHIATRY
- Efficacy of D-Cycloserine for Enhancing Response to Cognitive-Behavior Therapy for Panic Disorder
- (2009) Michael W. Otto et al. BIOLOGICAL PSYCHIATRY
- Severity of anxiety and work-related outcomes of patients with anxiety disorders
- (2009) Steven R. Erickson et al. DEPRESSION AND ANXIETY
- Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder
- (2009) Johannes Tauscher et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care
- (2009) E. Martin-Merino et al. FAMILY PRACTICE
- Cannabis and anxiety: a critical review of the evidence
- (2009) José Alexandre Crippa et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial
- (2009) Siegfried Kasper et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Mechanisms Contributing to the Phase-Dependent Regulation of Neurogenesis by the Novel Antidepressant, Agomelatine, in the Adult Rat Hippocampus
- (2009) Amélie Soumier et al. NEUROPSYCHOPHARMACOLOGY
- The psychiatric side-effects of rimonabant
- (2009) Fabrício A. Moreira et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Central CRH system in depression and anxiety — Evidence from clinical studies with CRH1 receptor antagonists
- (2008) Florian Holsboer et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Efficacy of Agomelatine in Generalized Anxiety Disorder
- (2008) Dan J. Stein et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Social anxiety disorder
- (2008) Murray B Stein et al. LANCET
- Functional Interactions between Endocannabinoid and CCK Neurotransmitter Systems May Be Critical for Extinction Learning
- (2008) Jasmeer P Chhatwal et al. NEUROPSYCHOPHARMACOLOGY
- Neurokinin1 Antagonists Potentiate Antidepressant Properties of Serotonin Reuptake Inhibitors, Yet Blunt Their Anxiogenic Actions: A Neurochemical, Electrophysiological and Behavioral Characterization
- (2008) Alain Gobert et al. NEUROPSYCHOPHARMACOLOGY
- Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder
- (2007) J. R. Strawn et al. DEPRESSION AND ANXIETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now